![]() |
|
![]() |
|
FacultyStatistical Manager, Data Coordinting Center, Boston University School of Public Health Ms. Ashba has worked over ten years in clinical research using epidemiologic methods and SAS programming. Her research interests include cancer epidemiology, survival analysis, and multivariate prediction models. Professor, Departments of Biostatistics and Epidemiology, Boston University, School of Public Health; Co-Director, MA in Clinical Investigation, Boston University School of Medicine Dr. Fish has a long history of research in the areas of clinical toxicology and emergency medicine. She has most recently focused on research ethics in general, and application of the federal regulations for waiver of informed consent in certain emergency research circumstances. Issues relating to the design of clinical research and ethical implications of study designs are Dr. Fish's areas of expertise. She is the former director of the IRB for the Boston University Medical Campus and Boston Medical Center. She is currently a member of the US Environmental Protection Agency's Human Studies Review Board. Adjunct Assistant Professor, School of Medicine Dr. Gloff develops strategies for rapidly moving medical products through the non-clinical and clinical trials process to marketing approval by the US Food and Drug Administration and international regulatory agencies. Dr. Gloff's expertise encompasses clinical and non-clinical pharmacokinetics, non-clinical toxicology, chemistry, manufacturing and control issues, and clinical operations. Dr. Gloff is a member of the Pharmaceutical Science Advisory Committee of the FDA's Center for Drug Evaluation and Research. Research Assistant Professor, Boston University, Department of Mathematics and Statistics Dr. Guo's research interests include conduct and analysis of various research projects at the Framingham Heart Study including general biostatistics, cross sectional and longitudinal studies, multivariate and survival analyses. His special interest is statistical genetics including linkage and/or association mapping and missing data studies. Adjunct Assistant Professor, Boston University, School of Medicine During eighteen years in the pharmaceutical and biotechnology industry, Ms. Halloran has achieved high level management positions in administration, product development and international operations. She established and developed Worldwide Training capabilities within clinical operations during ten years of the Parexel's company's rapid growth into a leading international contract research organization. Ms. Halloran's primary research interest is pharmaceutical business process improvement. Adjunct Assistant Professor, Department of Epidemiology, Boston University School of Public Health. Dr. McNair is the Senior Medical Director for Clinical Development at Vertex Pharmaceuticals Her research interests include clinical research ethics and research subject protection, ethical industry-sponsored drug development research, and interactions between Institutional Review Boards and the pharmaceutical industry. Associate Provost, Boston University Medical Campus; Director, Office of Clinical Research, Boston University Medical Center; Professor of Medicine, Boston University School of Medicine; Co-Director of the MA in Clinical Investigation, Boston University School of Medicine Dr. Moore is interested in the effect of foods on blood pressure and cardiac risk, dietary approaches to stop hypertension, and changing health behaviors via the internet. He is the author of The DASH Diet for Hypertension, a diet clinically proven to lower blood pressure levels and thereby reduce the risk of heart failure, stroke and kidney disease. Professor of Pharmacology, Boston University School of Medicine Dr. Walsh's research interests include gastrointestinal pharmacology, the toxicology of metal compounds, and pharmacokinetics. Projects have included the elucidation of the hypocholesterolemic effect of pharmacologic agents, evaluation of the gastrointestinal toxicity of lead, and a critical review of the toxicology of zinc. Pharmacokinetic studies have included work with opiate analgesics, phenothiazines, pyrimidine and purine analogue anticancer agents, antiepileptic agents, mercury-containing compounds, and butyric acid derivatives for sickle cell anemia and thalessemias. Adjunct Lecturer Ms. Yashon has a background in Law and Ethics and a specialty in genetics. She has developed activities for putting bioethics in the science classroom and has a number of published books on that topic and landmark legal cases as they apply to science. The legal and ethical background of clinical research is also an interest of hers and she has written articles on the history of the use of human subjects in experimentation. She is currently researching how legal education is addressing these issues. |
|
For more information please email maci@bu.edu or call Linda Zimmerman at 617-638-5704 |
|